Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations

Summary

The purpose of this study is to evaluate the long term safety and tolerability of PF-06649751 in Parkinson's disease patients who experience motor-fluctuations.

Timeline

Start

2017-07-06

Primary completion

2017-10-24

Completion

2017-10-25

Outcome

Outcome not reported

Stopped: “Terminated 25Sep17 due to parent study insufficient efficacy. Not due to safety”

Drugs

Indications